Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RANIMUSTINE for Bone marrow conditioning regimen: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 17 adverse event reports in the FDA FAERS database where RANIMUSTINE was used for Bone marrow conditioning regimen.

Most Reported Side Effects for RANIMUSTINE

Side Effect Reports % Deaths Hosp.
Febrile neutropenia 25 11.4% 8 7
Drug ineffective 24 10.9% 7 10
Haemolytic anaemia 16 7.3% 0 15
Thrombotic microangiopathy 16 7.3% 0 15
Hepatitis b 14 6.4% 2 0
Hypoxia 14 6.4% 0 11
Ventricular hypokinesia 14 6.4% 0 13
Acute kidney injury 13 5.9% 0 11
Bone marrow failure 12 5.5% 1 5
Cardiac failure 12 5.5% 0 11
Renal impairment 12 5.5% 1 2
Acute myeloid leukaemia 11 5.0% 9 1
Hypertension 11 5.0% 0 8
Myelodysplastic syndrome 11 5.0% 0 0
Myelosuppression 11 5.0% 0 8

Other Indications for RANIMUSTINE

Adult t-cell lymphoma/leukaemia (55) Diffuse large b-cell lymphoma (39) Plasma cell myeloma (13) Central nervous system lymphoma (10) Product used for unknown indication (8) Hodgkin's disease (7) Non-hodgkin's lymphoma (7) Lymphoma (5)

Other Drugs Used for Bone marrow conditioning regimen

FLUDARABINE (6,080) BUSULFAN (4,669) CYCLOPHOSPHAMIDE (4,485) MELPHALAN (2,368) LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN (1,884) THIOTEPA (1,551) ALEMTUZUMAB (1,122) ETOPOSIDE (936) CYTARABINE (833) THYMOCYTE IMMUNE GLOBULIN NOS (742)

Related Pages

RANIMUSTINE Full Profile All Bone marrow conditioning regimen Drugs RANIMUSTINE Demographics RANIMUSTINE Timeline